Basic fibroblast growth factor helps protect facial nerve cells in a freeze-induced paralysis model.

Severe axonal damage in the peripheral nerves results in retrograde degeneration towards the central side, leading to neuronal cell death, eventually resulting in incomplete axonal regeneration and functional recovery. Therefore, it is necessary to evaluate the facial nerve nucleus in models of faci...

Full description

Saved in:
Bibliographic Details
Main Authors: Shinji Iwata, Hiroyuki Yamada, Masato Teraoka, Takemichi Tanaka, Takuya Kimura, Tomonori Joko, Yasuhiko Tabata, Hiroyuki Wakisaka, Naohito Hato
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0312357
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856871415480320
author Shinji Iwata
Hiroyuki Yamada
Masato Teraoka
Takemichi Tanaka
Takuya Kimura
Tomonori Joko
Yasuhiko Tabata
Hiroyuki Wakisaka
Naohito Hato
author_facet Shinji Iwata
Hiroyuki Yamada
Masato Teraoka
Takemichi Tanaka
Takuya Kimura
Tomonori Joko
Yasuhiko Tabata
Hiroyuki Wakisaka
Naohito Hato
author_sort Shinji Iwata
collection DOAJ
description Severe axonal damage in the peripheral nerves results in retrograde degeneration towards the central side, leading to neuronal cell death, eventually resulting in incomplete axonal regeneration and functional recovery. Therefore, it is necessary to evaluate the facial nerve nucleus in models of facial paralysis, and investigate the efficacy of treatments, to identify treatment options for severe paralysis. Consequently, we aimed to examine the percentage of facial nerve cell reduction and the extent to which intratympanic administration of a basic fibroblast growth factor (bFGF) inhibits neuronal cell death in a model of severe facial paralysis. A severe facial paralysis model was induced in Hartley guinea pigs by freezing the facial canal. Animals were divided into two groups: one group was treated with gelatin hydrogel impregnated with bFGF (bFGF group) and the other was treated with gelatin hydrogel impregnated with saline (control group). Facial movement scoring, electrophysiological testing, and histological assessment of facial neurons were performed. The freezing-induced facial paralysis model showed a facial neuronal cell death rate of 29.0%; however, bFGF administration reduced neuronal cell death to 15.8%. Facial movement scores improved in the bFGF group compared with those in the control group. Intratympanic bFGF administration has a protective effect on facial neurons in a model of severe facial paralysis. These findings suggest a potential therapeutic approach for treating patients with refractory facial paralysis. Further studies are required to explore the clinical applicability of this treatment.
format Article
id doaj-art-f9ad577679da466da86f0aedec7f1fcf
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-f9ad577679da466da86f0aedec7f1fcf2025-02-12T05:30:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031235710.1371/journal.pone.0312357Basic fibroblast growth factor helps protect facial nerve cells in a freeze-induced paralysis model.Shinji IwataHiroyuki YamadaMasato TeraokaTakemichi TanakaTakuya KimuraTomonori JokoYasuhiko TabataHiroyuki WakisakaNaohito HatoSevere axonal damage in the peripheral nerves results in retrograde degeneration towards the central side, leading to neuronal cell death, eventually resulting in incomplete axonal regeneration and functional recovery. Therefore, it is necessary to evaluate the facial nerve nucleus in models of facial paralysis, and investigate the efficacy of treatments, to identify treatment options for severe paralysis. Consequently, we aimed to examine the percentage of facial nerve cell reduction and the extent to which intratympanic administration of a basic fibroblast growth factor (bFGF) inhibits neuronal cell death in a model of severe facial paralysis. A severe facial paralysis model was induced in Hartley guinea pigs by freezing the facial canal. Animals were divided into two groups: one group was treated with gelatin hydrogel impregnated with bFGF (bFGF group) and the other was treated with gelatin hydrogel impregnated with saline (control group). Facial movement scoring, electrophysiological testing, and histological assessment of facial neurons were performed. The freezing-induced facial paralysis model showed a facial neuronal cell death rate of 29.0%; however, bFGF administration reduced neuronal cell death to 15.8%. Facial movement scores improved in the bFGF group compared with those in the control group. Intratympanic bFGF administration has a protective effect on facial neurons in a model of severe facial paralysis. These findings suggest a potential therapeutic approach for treating patients with refractory facial paralysis. Further studies are required to explore the clinical applicability of this treatment.https://doi.org/10.1371/journal.pone.0312357
spellingShingle Shinji Iwata
Hiroyuki Yamada
Masato Teraoka
Takemichi Tanaka
Takuya Kimura
Tomonori Joko
Yasuhiko Tabata
Hiroyuki Wakisaka
Naohito Hato
Basic fibroblast growth factor helps protect facial nerve cells in a freeze-induced paralysis model.
PLoS ONE
title Basic fibroblast growth factor helps protect facial nerve cells in a freeze-induced paralysis model.
title_full Basic fibroblast growth factor helps protect facial nerve cells in a freeze-induced paralysis model.
title_fullStr Basic fibroblast growth factor helps protect facial nerve cells in a freeze-induced paralysis model.
title_full_unstemmed Basic fibroblast growth factor helps protect facial nerve cells in a freeze-induced paralysis model.
title_short Basic fibroblast growth factor helps protect facial nerve cells in a freeze-induced paralysis model.
title_sort basic fibroblast growth factor helps protect facial nerve cells in a freeze induced paralysis model
url https://doi.org/10.1371/journal.pone.0312357
work_keys_str_mv AT shinjiiwata basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel
AT hiroyukiyamada basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel
AT masatoteraoka basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel
AT takemichitanaka basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel
AT takuyakimura basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel
AT tomonorijoko basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel
AT yasuhikotabata basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel
AT hiroyukiwakisaka basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel
AT naohitohato basicfibroblastgrowthfactorhelpsprotectfacialnervecellsinafreezeinducedparalysismodel